Literature DB >> 3081448

Identity of hemolysins produced by Vibrio cholerae non-O1 and V. cholerae O1, biotype El Tor.

K Yamamoto, Y Ichinose, N Nakasone, M Tanabe, M Nagahama, J Sakurai, M Iwanaga.   

Abstract

Hemolysins purified from non-O1 Vibrio cholerae (non-O1 hemolysin) and a Vibrio cholerae O1, biotype El Tor (El Tor hemolysin) were investigated for their homology. The hemolysins were isolated from the culture supernatant fluids by ammonium sulfate precipitation and gel filtration on Sephadex G-100 columns. The purified hemolysins gave single bands with an identical mobility on conventional polyacrylamide gel disc electrophoresis. The molecular weights of the non-O1 and El Tor hemolysins were estimated to be about 60,000 by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and the amino acid compositions of the hemolysins were very similar. The specific activities of the hemolysins were identical, and both hemolysins were neutralized to the same extent with antisera against the homologous and heterologous hemolysins. Ouchterlony double immunodiffusion tests with both hemolysins and antihemolysin serum gave a common (fused) precipitin line. These data indicate that the non-O1 hemolysin is biologically, physicochemically, and immunologically indistinguishable from the El Tor hemolysin.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3081448      PMCID: PMC260987          DOI: 10.1128/iai.51.3.927-931.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Characteristics of non-cholera Vibrios isolated from cases of human diarrhoea.

Authors:  O R McIntyre; J C Feeley
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408

5.  Comparison of hemolysin, hemolysin-destructive factor and hemodigestive enzyme production by strains of Vibrio cholerae and Vibrio cholerae type El Tor.

Authors:  C M Kalsow; F S Newman
Journal:  Tex Rep Biol Med       Date:  1968

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Purification and characterization of Clostridium perfringens delta-toxin.

Authors:  J E Alouf; C Jolivet-Reynaud
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

8.  Complete amino acid analysis of proteins from a single hydrolysate.

Authors:  R J Simpson; M R Neuberger; T Y Liu
Journal:  J Biol Chem       Date:  1976-04-10       Impact factor: 5.157

9.  Purification and characterization of a hemolysin produced by Vibrio cholerae biotype El Tor: another toxic substance produced by cholera vibrios.

Authors:  T Honda; R A Finkelstein
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

10.  Purification of Pseudomonas aeruginosa proteases and microscopic characterization of pseudomonal protease-induced rabbit corneal damage.

Authors:  A S Kreger; L D Gray
Journal:  Infect Immun       Date:  1978-02       Impact factor: 3.441

View more
  34 in total

1.  Virulence profile and clonal relationship among the Vibrio cholerae isolates from ground and surface water in a cholera endemic area during rainy season.

Authors:  A K Goel; M Jain; P Kumar; D V Kamboj; L Singh
Journal:  Folia Microbiol (Praha)       Date:  2010-03-25       Impact factor: 2.099

Review 2.  Enteric bacterial toxins: mechanisms of action and linkage to intestinal secretion.

Authors:  C L Sears; J B Kaper
Journal:  Microbiol Rev       Date:  1996-03

3.  Vibrio cholerae serogroup O1 in northeast Thailand.

Authors:  T Kuyyakanond; S Nakamura; W Manmontri; M Iwanaga
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

4.  Biotype-specific probe for Vibrio cholerae serogroup O1.

Authors:  R A Alm; P A Manning
Journal:  J Clin Microbiol       Date:  1990-04       Impact factor: 5.948

5.  Experimental non-O group 1 Vibrio cholerae gastroenteritis in humans.

Authors:  J G Morris; T Takeda; B D Tall; G A Losonsky; S K Bhattacharya; B D Forrest; B A Kay; M Nishibuchi
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

6.  Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques.

Authors:  M M Levine; J B Kaper; D Herrington; G Losonsky; J G Morris; M L Clements; R E Black; B Tall; R Hall
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

7.  Nucleotide sequences and comparison of the hemolysin determinants of Vibrio cholerae El Tor RV79(Hly+) and RV79(Hly-) and classical 569B(Hly-).

Authors:  A E Rader; J R Murphy
Journal:  Infect Immun       Date:  1988-06       Impact factor: 3.441

8.  Cognate T and B cell interaction and association of follicular helper T cells with B cell responses in Vibrio cholerae O1 infected Bangladeshi adults.

Authors:  Rasheduzzaman Rashu; Taufiqur Rahman Bhuiyan; Mohammad Rubel Hoq; Lazina Hossain; Anik Paul; Ashraful Islam Khan; Fahima Chowdhury; Jason B Harris; Edward T Ryan; Stephen B Calderwood; Ana A Weil; Firdausi Qadri
Journal:  Microbes Infect       Date:  2018-12-21       Impact factor: 2.700

Review 9.  Genetics of Vibrio cholerae and its bacteriophages.

Authors:  A Guidolin; P A Manning
Journal:  Microbiol Rev       Date:  1987-06

10.  Purification and characterization of pili of a Vibrio cholerae non-O1 strain.

Authors:  T Yamashiro; N Nakasone; M Iwanaga
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.